|
Volumn 319, Issue 7222, 1999, Pages 1390-
|
UK review finds statins are cost effective in secondary prevention.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ARTICLE;
CARDIOVASCULAR DISEASE;
COST BENEFIT ANALYSIS;
ECONOMICS;
HUMAN;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
COST-BENEFIT ANALYSIS;
HUMANS;
|
EID: 0033610595
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.319.7222.1390 Document Type: Article |
Times cited : (3)
|
References (0)
|